Symbol:
Ube2k
Name:
ubiquitin-conjugating enzyme E2K
RGD ID:
1311626
Description:
Predicted to enable ubiquitin conjugating enzyme activity; ubiquitin protein ligase binding activity; and ubiquitin-ubiquitin ligase activity. Acts upstream of or within intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress. Predicted to be located in cytoplasm and filopodium tip. Predicted to be active in nucleus. Orthologous to human UBE2K (ubiquitin conjugating enzyme E2 K); PARTICIPATES IN ubiquitin/proteasome degradation pathway; INTERACTS WITH 2,4-dinitrotoluene; 2,6-dinitrotoluene; bisphenol A.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
E2-25k; Hip2; huntingtin interacting protein 2; Hypg; Lig; LOC289623; ubiquitin-conjugating enzyme E2 K; ubiquitin-conjugating enzyme E2-25K; ubiquitin-conjugating enzyme E2K (UBC1 homolog, yeast)
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
UBE2K (ubiquitin conjugating enzyme E2 K)
HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Ube2k (ubiquitin-conjugating enzyme E2K)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Ube2k (ubiquitin conjugating enzyme E2 K)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
UBE2K (ubiquitin conjugating enzyme E2 K)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
UBE2K (ubiquitin conjugating enzyme E2 K)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ube2k (ubiquitin conjugating enzyme E2 K)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
UBE2K (ubiquitin conjugating enzyme E2 K)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
UBE2K (ubiquitin conjugating enzyme E2 K)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Ube2k (ubiquitin conjugating enzyme E2 K)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
SLC30A1 (solute carrier family 30 member 1)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
UBE2K (ubiquitin conjugating enzyme E2 K)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Ube2k (ubiquitin-conjugating enzyme E2K)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ube2ka (ubiquitin-conjugating enzyme E2Ka (UBC1 homolog, yeast))
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER)
Danio rerio (zebrafish):
ube2kb (ubiquitin-conjugating enzyme E2Kb (UBC1 homolog, yeast))
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Ubc4
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
UBC1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
ubc-20
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
ubc-21
Alliance
DIOPT (InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
ube2k
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 14 43,011,681 - 43,077,825 (-) NCBI GRCr8 mRatBN7.2 14 42,658,016 - 42,718,899 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 14 42,658,016 - 42,718,630 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 14 43,011,647 - 43,072,105 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 14 44,311,686 - 44,372,016 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 14 42,791,658 - 42,852,126 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 14 44,289,247 - 44,348,691 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 14 44,289,247 - 44,348,691 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 14 44,108,859 - 44,168,755 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 14 45,349,287 - 45,411,823 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 14 45,354,342 - 45,414,183 (-) NCBI Celera 14 41,809,022 - 41,869,333 (-) NCBI Celera Cytogenetic Map 14 p11 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Ube2k Rat (1->4)-beta-D-glucan multiple interactions ISO Ube2k (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UBE2K mRNA CTD PMID:36331819 Ube2k Rat 1,2-dichloroethane increases expression ISO Ube2k (Mus musculus) 6480464 ethylene dichloride results in increased expression of UBE2K mRNA CTD PMID:28960355 Ube2k Rat 1,2-dimethylhydrazine multiple interactions ISO Ube2k (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2K mRNA CTD PMID:22206623 Ube2k Rat 1,2-dimethylhydrazine decreases expression ISO Ube2k (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of UBE2K mRNA CTD PMID:22206623 Ube2k Rat 17alpha-ethynylestradiol multiple interactions ISO Ube2k (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2K mRNA CTD PMID:17942748 Ube2k Rat 17alpha-ethynylestradiol increases expression ISO Ube2k (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of UBE2K mRNA CTD PMID:17555576 and PMID:17942748 Ube2k Rat 17beta-estradiol increases expression ISO Ube2k (Mus musculus) 6480464 Estradiol results in increased expression of UBE2K mRNA CTD PMID:39298647 Ube2k Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ube2k (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2K mRNA CTD PMID:17942748 Ube2k Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ube2k (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of UBE2K mRNA CTD PMID:21570461 Ube2k Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ube2k (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of UBE2K mRNA CTD PMID:19465110 Ube2k Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of UBE2K mRNA CTD PMID:21346803 Ube2k Rat 2,6-dimethoxyphenol multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Sodium Chloride co-treated with pyrogallol 1 and 3-dimethyl ether] results in decreased expression of UBE2K protein CTD PMID:38598786 Ube2k Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of UBE2K mRNA CTD PMID:21346803 Ube2k Rat 2-methylcholine affects expression ISO UBE2K (Homo sapiens) 6480464 beta-methylcholine affects the expression of UBE2K mRNA CTD PMID:21179406 Ube2k Rat 3H-1,2-dithiole-3-thione increases expression ISO Ube2k (Mus musculus) 6480464 1 and 2-dithiol-3-thione results in increased expression of UBE2K mRNA CTD PMID:15375163 Ube2k Rat 4,4'-sulfonyldiphenol increases expression ISO Ube2k (Mus musculus) 6480464 bisphenol S results in increased expression of UBE2K mRNA CTD PMID:39298647 Ube2k Rat acetylsalicylic acid increases expression ISO UBE2K (Homo sapiens) 6480464 Aspirin results in increased expression of UBE2K mRNA CTD PMID:11906190 Ube2k Rat aflatoxin B1 decreases expression ISO UBE2K (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of UBE2K mRNA CTD PMID:21641981 Ube2k Rat all-trans-retinoic acid decreases expression ISO UBE2K (Homo sapiens) 6480464 Tretinoin results in decreased expression of UBE2K mRNA CTD PMID:33167477 Ube2k Rat aminoglutethimide decreases expression ISO UBE2K (Homo sapiens) 6480464 Aminoglutethimide results in decreased expression of UBE2K protein CTD PMID:26102013 Ube2k Rat aristolochic acid A decreases expression ISO UBE2K (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of UBE2K mRNA CTD PMID:33212167 Ube2k Rat aristolochic acid A increases expression ISO UBE2K (Homo sapiens) 6480464 aristolochic acid I results in increased expression of UBE2K protein CTD PMID:33212167 Ube2k Rat Aroclor 1254 decreases expression ISO Ube2k (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of UBE2K mRNA CTD PMID:23650126 Ube2k Rat arsane affects methylation ISO UBE2K (Homo sapiens) 6480464 Arsenic affects the methylation of UBE2K gene CTD PMID:25304211 Ube2k Rat arsenic atom affects methylation ISO UBE2K (Homo sapiens) 6480464 Arsenic affects the methylation of UBE2K gene CTD PMID:25304211 Ube2k Rat atrazine decreases expression ISO UBE2K (Homo sapiens) 6480464 Atrazine results in decreased expression of UBE2K mRNA CTD PMID:22378314 Ube2k Rat benzo[a]pyrene decreases expression ISO UBE2K (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of UBE2K mRNA CTD PMID:20064835 Ube2k Rat benzo[a]pyrene increases expression ISO Ube2k (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of UBE2K mRNA CTD PMID:22228805 and PMID:27195522 Ube2k Rat benzo[a]pyrene diol epoxide I decreases expression ISO UBE2K (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:26238291 Ube2k Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UBE2K mRNA CTD PMID:25181051 Ube2k Rat bisphenol A decreases expression ISO Ube2k (Mus musculus) 6480464 bisphenol A results in decreased expression of UBE2K protein CTD PMID:35999755 Ube2k Rat bisphenol A increases methylation ISO UBE2K (Homo sapiens) 6480464 bisphenol A results in increased methylation of UBE2K gene CTD PMID:31601247 Ube2k Rat bisphenol A decreases expression ISO UBE2K (Homo sapiens) 6480464 bisphenol A results in decreased expression of UBE2K mRNA and bisphenol A results in decreased expression of UBE2K protein CTD PMID:29275510 and PMID:37567409 Ube2k Rat bisphenol AF increases expression ISO UBE2K (Homo sapiens) 6480464 bisphenol AF results in increased expression of UBE2K protein CTD PMID:34186270 Ube2k Rat Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of UBE2K protein CTD PMID:28903499 Ube2k Rat cadmium dichloride increases expression ISO Ube2k (Mus musculus) 6480464 Cadmium Chloride results in increased expression of UBE2K mRNA CTD PMID:20061341 Ube2k Rat cannabidiol multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of UBE2K protein CTD PMID:34122009 Ube2k Rat chenodeoxycholic acid multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UBE2K mRNA CTD PMID:32152650 Ube2k Rat chlorpyrifos increases expression ISO Ube2k (Mus musculus) 6480464 Chlorpyrifos results in increased expression of UBE2K mRNA CTD PMID:29156651 Ube2k Rat cisplatin decreases expression ISO UBE2K (Homo sapiens) 6480464 Cisplatin results in decreased expression of UBE2K mRNA CTD PMID:27594783 Ube2k Rat clofibrate increases expression ISO Ube2k (Mus musculus) 6480464 Clofibrate results in increased expression of UBE2K mRNA CTD PMID:23811191 Ube2k Rat cobalt dichloride increases expression ISO UBE2K (Homo sapiens) 6480464 cobaltous chloride results in increased expression of UBE2K mRNA CTD PMID:19320972 Ube2k Rat copper(II) sulfate increases expression ISO UBE2K (Homo sapiens) 6480464 Copper Sulfate results in increased expression of UBE2K mRNA CTD PMID:19549813 Ube2k Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of UBE2K mRNA CTD PMID:26577399 Ube2k Rat Cuprizon multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of UBE2K protein CTD PMID:34122009 Ube2k Rat cyclosporin A decreases expression ISO UBE2K (Homo sapiens) 6480464 Cyclosporine results in decreased expression of UBE2K mRNA CTD PMID:22147139 Ube2k Rat cyclosporin A multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UBE2K mRNA CTD PMID:32152650 Ube2k Rat deoxycholic acid multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UBE2K mRNA CTD PMID:32152650 Ube2k Rat dieldrin increases response to substance ISO UBE2K (Homo sapiens) 6480464 UBE2K gene mutant form results in increased susceptibility to Dieldrin CTD PMID:32421776 Ube2k Rat doxorubicin decreases expression ISO UBE2K (Homo sapiens) 6480464 Doxorubicin results in decreased expression of UBE2K mRNA CTD PMID:29803840 Ube2k Rat ethanol affects splicing ISO Ube2k (Mus musculus) 6480464 Ethanol affects the splicing of UBE2K mRNA CTD PMID:30319688 Ube2k Rat ethyl methanesulfonate decreases expression ISO UBE2K (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of UBE2K mRNA CTD PMID:23649840 Ube2k Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of UBE2K mRNA CTD PMID:24136188 Ube2k Rat folic acid multiple interactions ISO Ube2k (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2K mRNA CTD PMID:22206623 Ube2k Rat formaldehyde decreases expression ISO UBE2K (Homo sapiens) 6480464 Formaldehyde results in decreased expression of UBE2K mRNA CTD PMID:23649840 Ube2k Rat furan decreases expression EXP 6480464 furan results in decreased expression of UBE2K mRNA CTD PMID:25539665 Ube2k Rat furfural multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UBE2K protein and [Sodium Chloride co-treated with Furaldehyde] results in increased expression of UBE2K protein CTD PMID:38598786 Ube2k Rat glycochenodeoxycholic acid multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UBE2K mRNA CTD PMID:32152650 Ube2k Rat glycocholic acid multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UBE2K mRNA CTD PMID:32152650 Ube2k Rat glycodeoxycholic acid multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UBE2K mRNA CTD PMID:32152650 Ube2k Rat isotretinoin decreases expression ISO UBE2K (Homo sapiens) 6480464 Isotretinoin results in decreased expression of UBE2K mRNA CTD PMID:20436886 Ube2k Rat ivermectin decreases expression ISO UBE2K (Homo sapiens) 6480464 Ivermectin results in decreased expression of UBE2K protein CTD PMID:32959892 Ube2k Rat lead diacetate affects expression EXP 6480464 lead acetate affects the expression of UBE2K protein CTD PMID:36539177 Ube2k Rat lead(0) affects splicing ISO UBE2K (Homo sapiens) 6480464 Lead affects the splicing of UBE2K mRNA CTD PMID:28903495 Ube2k Rat mechlorethamine increases expression ISO Ube2k (Mus musculus) 6480464 Mechlorethamine results in increased expression of UBE2K mRNA CTD PMID:17107856 Ube2k Rat methidathion decreases expression ISO Ube2k (Mus musculus) 6480464 methidathion results in decreased expression of UBE2K mRNA CTD PMID:34813904 Ube2k Rat methyl methanesulfonate decreases expression ISO UBE2K (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of UBE2K mRNA CTD PMID:23649840 Ube2k Rat methylmercury chloride increases expression ISO Ube2k (Mus musculus) 6480464 methylmercuric chloride results in increased expression of UBE2K mRNA CTD PMID:20061341 Ube2k Rat methylmercury chloride increases expression ISO UBE2K (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of UBE2K mRNA CTD PMID:28001369 Ube2k Rat methylparaben decreases expression ISO UBE2K (Homo sapiens) 6480464 methylparaben results in decreased expression of UBE2K mRNA CTD PMID:31745603 Ube2k Rat N-methyl-4-phenylpyridinium decreases expression ISO Ube2k (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of UBE2K protein CTD PMID:26558463 Ube2k Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of UBE2K mRNA CTD PMID:24136188 Ube2k Rat nimesulide increases expression EXP 6480464 nimesulide results in increased expression of UBE2K mRNA CTD PMID:24136188 Ube2k Rat paracetamol decreases expression ISO UBE2K (Homo sapiens) 6480464 Acetaminophen results in decreased expression of UBE2K mRNA CTD PMID:21420995 Ube2k Rat pentachlorophenol increases expression ISO Ube2k (Mus musculus) 6480464 Pentachlorophenol results in increased expression of UBE2K mRNA CTD PMID:23892564 Ube2k Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Ube2k (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UBE2K mRNA CTD PMID:36331819 Ube2k Rat pirinixic acid increases expression ISO Ube2k (Mus musculus) 6480464 pirinixic acid results in increased expression of UBE2K mRNA CTD PMID:15375163 and PMID:23811191 Ube2k Rat rotenone increases expression ISO UBE2K (Homo sapiens) 6480464 Rotenone results in increased expression of UBE2K mRNA CTD PMID:33512557 Ube2k Rat SB 431542 multiple interactions ISO UBE2K (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of UBE2K protein CTD PMID:37664457 Ube2k Rat sodium arsenate increases expression ISO Ube2k (Mus musculus) 6480464 sodium arsenate results in increased expression of UBE2K mRNA CTD PMID:21795629 Ube2k Rat sodium arsenite multiple interactions ISO UBE2K (Homo sapiens) 6480464 TP53 protein affects the reaction [sodium arsenite results in increased expression of UBE2K mRNA] CTD PMID:16966095 Ube2k Rat sodium arsenite increases expression ISO UBE2K (Homo sapiens) 6480464 sodium arsenite results in increased expression of UBE2K mRNA CTD PMID:38568856 Ube2k Rat sodium chloride multiple interactions ISO UBE2K (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UBE2K protein more ... CTD PMID:38598786 Ube2k Rat sodium dichromate increases expression ISO Ube2k (Mus musculus) 6480464 sodium bichromate results in increased expression of UBE2K mRNA CTD PMID:22155349 Ube2k Rat sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of UBE2K mRNA CTD PMID:22561333 Ube2k Rat tamoxifen affects expression ISO Ube2k (Mus musculus) 6480464 Tamoxifen affects the expression of UBE2K mRNA CTD PMID:17555576 Ube2k Rat tert-butyl hydroperoxide increases expression ISO UBE2K (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of UBE2K mRNA CTD PMID:15336504 Ube2k Rat titanium dioxide decreases methylation ISO Ube2k (Mus musculus) 6480464 titanium dioxide results in decreased methylation of UBE2K gene CTD PMID:35295148 Ube2k Rat valproic acid affects expression ISO UBE2K (Homo sapiens) 6480464 Valproic Acid affects the expression of UBE2K mRNA CTD PMID:25979313 Ube2k Rat valproic acid decreases expression ISO UBE2K (Homo sapiens) 6480464 Valproic Acid results in decreased expression of UBE2K mRNA CTD PMID:23179753 and PMID:27188386 Ube2k Rat vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of UBE2K gene CTD PMID:31682807 Ube2k Rat vorinostat decreases expression ISO UBE2K (Homo sapiens) 6480464 vorinostat results in decreased expression of UBE2K mRNA CTD PMID:27188386
Imported Annotations - KEGG (archival)
(1->4)-beta-D-glucan (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 2,4-dinitrotoluene (EXP) 2,6-dimethoxyphenol (ISO) 2,6-dinitrotoluene (EXP) 2-methylcholine (ISO) 3H-1,2-dithiole-3-thione (ISO) 4,4'-sulfonyldiphenol (ISO) acetylsalicylic acid (ISO) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) aminoglutethimide (ISO) aristolochic acid A (ISO) Aroclor 1254 (ISO) arsane (ISO) arsenic atom (ISO) atrazine (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) Brodifacoum (EXP) cadmium dichloride (ISO) cannabidiol (ISO) chenodeoxycholic acid (ISO) chlorpyrifos (ISO) cisplatin (ISO) clofibrate (ISO) cobalt dichloride (ISO) copper(II) sulfate (ISO) Cuprizon (EXP,ISO) cyclosporin A (ISO) deoxycholic acid (ISO) dieldrin (ISO) doxorubicin (ISO) ethanol (ISO) ethyl methanesulfonate (ISO) flutamide (EXP) folic acid (ISO) formaldehyde (ISO) furan (EXP) furfural (ISO) glycochenodeoxycholic acid (ISO) glycocholic acid (ISO) glycodeoxycholic acid (ISO) isotretinoin (ISO) ivermectin (ISO) lead diacetate (EXP) lead(0) (ISO) mechlorethamine (ISO) methidathion (ISO) methyl methanesulfonate (ISO) methylmercury chloride (ISO) methylparaben (ISO) N-methyl-4-phenylpyridinium (ISO) nefazodone (EXP) nimesulide (EXP) paracetamol (ISO) pentachlorophenol (ISO) perfluorooctane-1-sulfonic acid (ISO) pirinixic acid (ISO) rotenone (ISO) SB 431542 (ISO) sodium arsenate (ISO) sodium arsenite (ISO) sodium chloride (ISO) sodium dichromate (EXP,ISO) tamoxifen (ISO) tert-butyl hydroperoxide (ISO) titanium dioxide (ISO) valproic acid (ISO) vinclozolin (EXP) vorinostat (ISO)
Ube2k (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 14 43,011,681 - 43,077,825 (-) NCBI GRCr8 mRatBN7.2 14 42,658,016 - 42,718,899 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 14 42,658,016 - 42,718,630 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 14 43,011,647 - 43,072,105 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 14 44,311,686 - 44,372,016 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 14 42,791,658 - 42,852,126 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 14 44,289,247 - 44,348,691 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 14 44,289,247 - 44,348,691 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 14 44,108,859 - 44,168,755 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 14 45,349,287 - 45,411,823 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 14 45,354,342 - 45,414,183 (-) NCBI Celera 14 41,809,022 - 41,869,333 (-) NCBI Celera Cytogenetic Map 14 p11 NCBI
UBE2K (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 4 39,698,136 - 39,782,792 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 4 39,698,109 - 39,782,792 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 4 39,699,756 - 39,784,412 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 4 39,376,266 - 39,457,977 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 4 39,522,436 - 39,604,148 NCBI Celera 4 40,137,995 - 40,223,124 (+) NCBI Celera Cytogenetic Map 4 p14 NCBI HuRef 4 39,024,547 - 39,109,580 (+) NCBI HuRef CHM1_1 4 39,699,339 - 39,784,070 (+) NCBI CHM1_1 T2T-CHM13v2.0 4 39,667,902 - 39,752,430 (+) NCBI T2T-CHM13v2.0
Ube2k (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 5 65,694,588 - 65,756,332 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 5 65,694,576 - 65,756,331 (+) Ensembl GRCm39 Ensembl GRCm38 5 65,537,245 - 65,598,989 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 5 65,537,233 - 65,598,988 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 5 65,928,500 - 65,990,228 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 5 65,816,406 - 65,878,063 (+) NCBI MGSCv36 mm8 Celera 5 62,815,933 - 62,878,205 (+) NCBI Celera Cytogenetic Map 5 C3.1 NCBI cM Map 5 33.72 NCBI
Ube2k (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955443 7,618,379 - 7,656,305 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955443 7,618,379 - 7,655,542 (-) NCBI ChiLan1.0 ChiLan1.0
UBE2K (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 3 39,886,781 - 39,972,600 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 4 40,079,239 - 40,164,593 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 4 34,026,942 - 34,111,923 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 4 39,877,966 - 39,960,402 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 4 39,877,966 - 39,960,397 (+) Ensembl panpan1.1 panPan2
UBE2K (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 3 72,713,035 - 72,780,199 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 3 72,717,236 - 72,780,210 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 3 75,259,911 - 75,327,198 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 3 73,485,595 - 73,553,473 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 3 73,485,593 - 73,553,418 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 3 72,752,394 - 72,820,149 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 3 72,898,341 - 72,966,163 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 3 73,284,799 - 73,352,656 (-) NCBI UU_Cfam_GSD_1.0
Ube2k (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405285 38,975,456 - 39,053,214 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936482 7,244,967 - 7,323,266 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936482 7,244,972 - 7,323,263 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
UBE2K (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 8 30,887,830 - 30,963,762 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 8 30,887,784 - 30,961,685 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 8 32,580,147 - 32,654,102 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
UBE2K (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 27 10,535,091 - 10,618,659 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 27 10,539,402 - 10,618,573 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666047 56,921,431 - 57,007,501 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Ube2k (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 1026 Count of miRNA genes: 346 Interacting mature miRNAs: 477 Transcripts: ENSRNOT00000030485 Prediction methods: Microtar, Miranda Result types: miRGate_prediction
2313089 Bss81 Bone structure and strength QTL 81 3.4 0.0001 body length (VT:0001256) body length, nose to rump (CMO:0000079) 14 37669719 82669719 Rat 1581500 Renag1 Renal agenesis QTL 1 kidney development trait (VT:0000527) percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940) 14 8170668 68298175 Rat 10755459 Coatc15 Coat color QTL 15 0.01681 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 14 19836944 64836944 Rat 70214 Niddm28 Non-insulin dependent diabetes mellitus QTL 28 4.06 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 14 39998251 75582726 Rat 1300154 Bp189 Blood pressure QTL 189 3.04 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 14 30883777 68757901 Rat 70187 Pancm5 Pancreatic morphology QTL 5 16.7 pancreas mass (VT:0010144) pancreas weight to body weight ratio (CMO:0000630) 14 30320092 80829842 Rat 631523 Pia13 Pristane induced arthritis QTL 13 3.3 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 14 40793460 98037301 Rat 1358296 Ael3 Aortic elastin QTL 3 3.7 0.00051 aorta elastin amount (VT:0003905) aortic elastin 14 8267090 53267090 Rat 2313100 Bss82 Bone structure and strength QTL 82 3 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 14 37669719 82669719 Rat 7387267 Uae42 Urinary albumin excretion QTL 42 0.61 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 14 22167967 67167967 Rat 631839 Niddm37 Non-insulin dependent diabetes mellitus QTL 37 3.37 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 14 11030622 95876975 Rat 2313397 Coatc1 Coat color QTL1 coat/hair pigmentation trait (VT:0010463) coat/hair color measurement (CMO:0001808) 14 18541332 63541332 Rat 2313048 Bss84 Bone structure and strength QTL 84 3.1 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 14 37669719 82669719 Rat 1300136 Rf22 Renal function QTL 22 3.9 renal blood flow trait (VT:2000006) absolute change in renal vascular resistance (CMO:0001900) 14 42262529 95023211 Rat 2302045 Pia39 Pristane induced arthritis QTL 39 4.9 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G2a level (CMO:0002116) 14 8267090 53267090 Rat 738037 Hcas6 Hepatocarcinoma susceptibility QTL 6 2.93 liver integrity trait (VT:0010547) liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464) 14 39057237 83368335 Rat 2313084 Bss83 Bone structure and strength QTL 83 2.9 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 14 37669719 82669719 Rat
RH130202
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 14 42,659,388 - 42,659,586 (+) MAPPER mRatBN7.2 Rnor_6.0 14 44,290,620 - 44,290,817 NCBI Rnor6.0 Rnor_5.0 14 44,110,232 - 44,110,429 UniSTS Rnor5.0 RGSC_v3.4 14 45,350,660 - 45,350,857 UniSTS RGSC3.4 Celera 14 41,810,395 - 41,810,592 UniSTS Cytogenetic Map 14 p11 UniSTS
RH141776
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 14 42,663,184 - 42,663,375 (+) MAPPER mRatBN7.2 Rnor_6.0 14 44,294,416 - 44,294,606 NCBI Rnor6.0 Rnor_5.0 14 44,114,028 - 44,114,218 UniSTS Rnor5.0 RGSC_v3.4 14 45,354,456 - 45,354,646 UniSTS RGSC3.4 Celera 14 41,814,191 - 41,814,381 UniSTS Cytogenetic Map 14 p11 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000030485 ⟹ ENSRNOP00000032265
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 42,658,016 - 42,718,554 (-) Ensembl Rnor_6.0 Ensembl 14 44,289,247 - 44,348,691 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000099891 ⟹ ENSRNOP00000085062
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 42,658,016 - 42,713,094 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000103920 ⟹ ENSRNOP00000085882
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 42,661,971 - 42,718,630 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000105695 ⟹ ENSRNOP00000079243
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 42,658,016 - 42,718,342 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000116564 ⟹ ENSRNOP00000096375
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 42,662,024 - 42,718,548 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000118995 ⟹ ENSRNOP00000083068
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 42,662,172 - 42,718,554 (-) Ensembl
RefSeq Acc Id:
NM_001106006 ⟹ NP_001099476
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 43,011,681 - 43,072,214 (-) NCBI mRatBN7.2 14 42,658,016 - 42,718,554 (-) NCBI Rnor_6.0 14 44,289,247 - 44,348,691 (-) NCBI Rnor_5.0 14 44,108,859 - 44,168,755 (-) NCBI RGSC_v3.4 14 45,349,287 - 45,411,823 (-) RGD Celera 14 41,809,022 - 41,869,333 (-) RGD
Sequence:
GCGCATGCGCGGACCCGGCGCCATTTTGGTGGCCGGGCGCGGAGGTGATTCTACACTGAGGGGGAACGCGACGGCAAGGGTGGCAGTGGCAGCGTTCGTGTGCTCGGGTCTGAATCACTGAGGGAGGA GGCGGTGGAGGAAGAGGTGGCAGCGGTGGCGGTGGTCGTAGCGGTGGCGGAGGAGGCGGGTACGAATCAGCTGCGGGCAGAGACATGGCCAACATCGCGGTGCAGCGAATCAAGCGGGAGTTCAAGGA GGTGCTGAAGAGCGAGGAGACGAGCAAAAATCAAATTAAAGTAGATCTTGTAGATGAGAATTTTACAGAATTAAGAGGAGAAATAGCAGGACCTCCAGACACACCGTATGAAGGTGGAAGATATCAAC TAGAGATAAAAATACCAGAAACATATCCATTTAACCCCCCTAAGGTCCGGTTTATCACTAAAATATGGCACCCTAATATTAGTTCCGTCACAGGGGCTATTTGTTTGGATATCCTGAAAGATCAATGG GCAGCAGCAATGACTCTGCGCACAGTATTATTGTCATTGCAAGCACTGCTGGCCGCTGCAGAACCAGATGACCCCCAAGATGCAGTAGTAGCAAATCAGTACAAACAAAATCCTGAAATGTTCAAGCA GACAGCTCGACTTTGGGCACACGTGTATGCTGGAGCACCAGTGTCTAGTCCAGAATACACCAAAAAAATAGAAAACCTCTGTGCTATGGGTTTTGATAGGAACGCAGTAATAGTGGCCTTGTCTTCAA AATCATGGGATGTAGAGACTGCAACAGAACTGCTTCTGAGTAACTGAGGCACAGGAGCTGCCAGCCACGCTCGCCCCTTCCTGAGGAGCGTCCACACCTGTCATTTTTAGGATTCTGCATAAATTTCT TTTAAACTGGCATTCTTGCCTAATGATGTTACCTAGGCACCATTGGAGACTGCAAAAAAAAAAAAAAAAATTACCTGCTCTGTAAATAAAGCTAATTAAACGTCTGTGTAAATTTAAAAAGGGAAAAT ACTTTAATTTTTTTCTTGGTAGTGTAAAAATCCTTTGAGCTAAGCTAAAACCATGGGAAAACATGCTACTTTAGTGTTTAGCAGTGTGACAGACTAGTGAGTTTGCTTCAGGGTTCTGTTGAGTAACT AGGATAACACTCGAGTGTTGGCCCTACCTTGTGGAGTAGCATCACAGTCCCTCAAGCCTGAACATGGATCCTCTGTGCCTGTGACTTACTTGCATGCTTGACCTCTTAGAACGGGTAGCTGAAAGACC ACCCTTTTAAGCGTTAGGACATTTTTGAATTATGAGATTTATCCTGATTTAAAGATGGTGACCTAATCAGAGCTTTTTCGTCCCTGTGGACTGGTGGGGACTGTCTTTTTTCCTTGTCACCATCCAGA GTGGAGAGTCTCATGGTCAGTTTCTTTTGTGTTTGGTGGGAAACGTGCTGAGGAACAGTGTCCCGTGTTCCACTTTTAGCTCATAGGTTTGGAATGTTTTGTCCAAGCTCTTCACTTTGTAAGTAGGA ATGTAACAAAGGAGCTGCCAATTTCATTTCTCTTATAAAAGGAGAAAATACTTGATGTTGCAGTATTTCCAGATTTAATAAAAGGACACTGCTTAGTTTTTCAGTGATTTTGACATTAAGTTTTAAAA TGATAAAGTCTTTGGAAACTTGAAGGGTGCAGCACCTGTCCCCTCGTGCTCAGCCTGAGTTGGGCGTGACAGTTTTCTTTGTCAGACACTTGAGTTACTGCACTCCCCATGTTGACACACGAAAGCTG TGGTGTCTCGCTGTACATACCAGATGCACATAGGAACAGGGGTGTGCTCTAAATCTAGCTTTTTATGATGTTTCTGATAATGTGAGAATTGAAACTTTACCTTTTCTTGTACATAGACTTCCTGTCCT TAGTAACTGTCGTATCTCATTCTAAGTTCCAAAGCTTGAAAATTAATAGTTTTGCAAATTGGTTTTGCAAACTCAGATACTTAATTTAACCATCTTTATTAAGGTTCAAGTGAATTTATGTAGGCAGT TGTTACATAGGAGATATAATTAAAGATTTTGAGAACCAATGCATAAATTACAGAAATGTAATGGAATCAGACTGAGTTAAAGTAAGGCTGTATGTATATTGAAAGTCATATTCTAAAAGGTTTGTTTC TCGAAGAGTTGATTGATCTTATAGTCATGAAGTATTTCAAAAATACTTTCTGAACCTATTAACTCAGCATAACTTCATTTGACTTTTAATAATCTCGATACTACAAGCAATAAATGAGCCATCAATAC ATTACATTACAGATGTGAAGGTTCTTCCAGCAGCTCATAAGGCTTTCCCAGTCAACAGTGACTTGGGCTCGCTGCCCTGCACTAAGCTCAGGCTGCTGCTCCCCATGTCTGTGATGCACACATTCCCG CCCGCGGCAGCTACATCCTTATTGCTGTAGGTCATTTTATAAAGATGCCAAAGGAGACAAGGTTTTCTTTATTTTCAATAGCTGGGACTTTGTCTTTTTCTTTATCTTCTCAGATAAGCTGGAAATGT CAGAAATTCTGGACCGTTGACCTCCGTTGTCAGTTAGGACTGTTTAATGGAGGGTGGTAACATTGATATTTAGGTATGGAAATGCATACATCTTCCTTGCATTCCTCTCTGCCTGCATTGTCAGGGCG TAGTGTCTGGGTAGACGTCAAGCAGCACCACTTTGTCTTGGAGGCAGCTGTTTCTACTTATTGTCTTTTTTTTTTTTTTTTTTGGTTCTTTTTTTTCGGAGCTGGGGACTGAACCCAGGGCCTTGCGC TTCCTAGGTAAGCGCTCTACCACTGAGCTAAATCCCCAGACCCTTTGTTTTTTATTTTATATTTTTTGCATATTGGTTTCAGACAGCTTCCATGTGTGCATATAACATGGTGTCATAGATTTTACATG ATTATGCTATCATCTCTGTGACCCTAGAACTTGGGTGTGAGAACCATGAACTCAAGGCTGTCCAGGTTTCATACACCAGGCTGCTTGGGGGTTTTCTTCATTTAATATGATCATAGACCTTCTGTGGG ACTTCCTCACTGTTCTCCTGGTGGTCTTTTTATTCTTTTATTTCCCATCTTGTAGGTTTAGTTCATCTTAAAGCAGAGGCTTAGGCTTCTATCCTGGTTTTACATACATTTAGGAAAACTACTCAAAA TCTAGATCTAGTAAAACTTGCCCCGATGGAAATTATTTTTGTAAATTTCATTTGAGAGTTTATCATCTTAGTGAGTCCTGAAAAGGTTCTGTCTTGGTCTAGGCGTGGTGGCGCCTTTACTCCCATGC TCTGGAAAGGGAAAGGCAGGCAGCTTCTGTGAGACACCTCGTGGGAGGTGTGTGTCCAGTCTTAACCCCTACTCCACAGTCTTAGTGAAATCCCAGTTAGGATTCCTTGGTACTCGCTGGTCCTCTGA CATGCTTTTACATAATCCAGCCTTTTTTTCCTGAGCCTATGCCTGACTTTTAGTATAAAACTTTGAGCATGTTGGGAACTTTGAATTCAAAAAACATGTAAGTGTTTGGAATCAAATATTTTGCCTTT GAGAAGTGTAACTTACCTATCAAATGAGATTAAAACATTTTTTGAAATTTTTTTATATTTCTGATTGTTGATGGCATTTAACACTATGCAAAAACTCAAGTATCTGCAGAAAACAGTTGACAGCGGGC TTCGCTCCCACTGTAGAACACAGCGTGTTATATATCACTGGTGAGGCTGTTGACCAAGTTGACAAATGTGGAAGCCGGGTTGTGAGCGTAGGCCTCACACAGCTTTTAAAACTGCAGGAGAGTTACGG TTTTGCAGTCTAGTGTAGCAGCACAGAAGTGAAGTTTCGGTAGGGTACGGGCTTAATGCGAATTTGGGAATCAGCAGTGGAGTCAGGTATACTGTACATAGATGGATTCCATGTGTAGATGGGAAAAG GAAGGTATCTGTTCATACTGAGCTTTATTTCATGACTGATAAAACTGTTCTGTATTAATTACTTTTTCTAGTTCCAAGGAGTTGATCTTTCAAGTCACATTTTCATCTTTCAGAATCTGGTTTAAGTC AGCGTGTGCCCATCAGCCTGTTGGTGTCACTGAGGAACAGCCTTTTCTCGAACAGTGTCTACGGTTCTGATGCACAGATACACTGTTTGCAGTGTTGCAATGCAGAGAACAAACTGCAGCTTACATTG GTGCGGGTGAGGGTGGGGGTTGTTGGCGTTTCCCTTACCTATCTTGCTACTGCTTTCTCAGACTGCCAGAACCCCTGCCTGCAGGCGTCACTGGAAGGTGTCCCGATTGTGTTGTCTGTGGCATGGTT ACTCCCACCACGCTGCTGTTTGTCCTCAGGTGTGGCACAGGTCTCTTTGGTTCTAGGCAAGTGGATCAAGTCACTGCACTGTGCTTTCACTGATCGTGTCTGCTTACCGTCACCTACTTATACAGGCA TCATAAAAGCTAGACAATTTCTTTGGGGGAAAAGAGACTTATTTAATGTAATTTAAAGAGTTTTCCAATAAAAAATGGAATATTATTAAATATCTATTTTTAGCTTTCAGCCTTTGATGGTGCTTTGT CGTGCTTTGCTGGAAGCTACTGACGTTATAGGGATTTCCATTAACCTCACTTTGGAAGAGCCTTGCTTGTTAGCTTCTTTAGGTCTCTGAACAGTTTGTTAGTGATGGTAAATTCTGTAGGAGGGTCT ATTCTGAGCCATTAACTTCTTGTAAGGGGAAAACGGGCTGGTTACCAGAAACACTGCTGAAGCAGGGCGGCTGTGGGTGGAGGGTCGGGCGTCTGTCTTGAGAATTAAAAACTACGAAACACTTTTGT ATACAAATTTTTAAAAAAAAATAAACACATTTTTAAAGATGTTGAACTTTCCCCCTTATTGGGAATTCTTAAAAATAAATGCATGCACATTCCCCCCCGCCCCCCGT
hide sequence
RefSeq Acc Id:
XM_039091716 ⟹ XP_038947644
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 43,015,636 - 43,077,825 (-) NCBI mRatBN7.2 14 42,659,353 - 42,718,899 (-) NCBI
RefSeq Acc Id:
XM_039091717 ⟹ XP_038947645
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 43,015,636 - 43,072,270 (-) NCBI mRatBN7.2 14 42,659,353 - 42,718,548 (-) NCBI
RefSeq Acc Id:
XM_063272925 ⟹ XP_063128995
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 43,015,636 - 43,072,152 (-) NCBI
RefSeq Acc Id:
XM_063272926 ⟹ XP_063128996
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 43,015,636 - 43,071,961 (-) NCBI
RefSeq Acc Id:
XM_063272927 ⟹ XP_063128997
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 43,015,636 - 43,039,156 (-) NCBI
RefSeq Acc Id:
NP_001099476 ⟸ NM_001106006
- UniProtKB:
A6JDD4 (UniProtKB/TrEMBL), A0A8I6AV01 (UniProtKB/TrEMBL)
- Sequence:
MANIAVQRIKREFKEVLKSEETSKNQIKVDLVDENFTELRGEIAGPPDTPYEGGRYQLEIKIPETYPFNPPKVRFITKIWHPNISSVTGAICLDILKDQWAAAMTLRTVLLSLQALLAAAEPDDPQDA VVANQYKQNPEMFKQTARLWAHVYAGAPVSSPEYTKKIENLCAMGFDRNAVIVALSSKSWDVETATELLLSN
hide sequence
Ensembl Acc Id:
ENSRNOP00000032265 ⟸ ENSRNOT00000030485
RefSeq Acc Id:
XP_038947644 ⟸ XM_039091716
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6A2L8 (UniProtKB/TrEMBL), A0A8I6AV01 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038947645 ⟸ XM_039091717
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I5ZMB3 (UniProtKB/TrEMBL), A6JDD3 (UniProtKB/TrEMBL), A0A8I6AV01 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000079243 ⟸ ENSRNOT00000105695
Ensembl Acc Id:
ENSRNOP00000083068 ⟸ ENSRNOT00000118995
Ensembl Acc Id:
ENSRNOP00000085882 ⟸ ENSRNOT00000103920
Ensembl Acc Id:
ENSRNOP00000096375 ⟸ ENSRNOT00000116564
Ensembl Acc Id:
ENSRNOP00000085062 ⟸ ENSRNOT00000099891
RefSeq Acc Id:
XP_063128995 ⟸ XM_063272925
- Peptide Label:
isoform X3
- UniProtKB:
A6JDD5 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128996 ⟸ XM_063272926
- Peptide Label:
isoform X3
- UniProtKB:
A6JDD5 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128997 ⟸ XM_063272927
- Peptide Label:
isoform X3
- UniProtKB:
A6JDD5 (UniProtKB/TrEMBL)
RGD ID: 13699311
Promoter ID: EPDNEW_R9836
Type: initiation region
Name: Ube2k_1
Description: ubiquitin-conjugating enzyme E2K
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 14 44,348,663 - 44,348,723 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2011-08-01
Ube2k
ubiquitin-conjugating enzyme E2K
Ube2k
ubiquitin-conjugating enzyme E2K (UBC1 homolog, yeast)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-05-15
Ube2k
ubiquitin-conjugating enzyme E2K (UBC1 homolog, yeast)
Hip2
huntingtin interacting protein 2
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Hip2
huntingtin interacting protein 2
Hip2_predicted
huntingtin interacting protein 2 (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Hip2_predicted
huntingtin interacting protein 2 (predicted)
Symbol and Name status set to approved
70820
APPROVED